Intellia Therapeutics (NTLA) Amortizatization of Intangibles (2019 - 2026)

Intellia Therapeutics has reported Amortizatization of Intangibles over the past 8 years, most recently at $535000.0 for Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 76.54% to $535000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Mar 2026, up 246.79% year-over-year, with the annual reading at $6.2 million for FY2025, N/A changed from the prior year.
  • Amortizatization of Intangibles was $535000.0 for Q1 2026 at Intellia Therapeutics, down from $3.6 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $7.9 million in Q3 2023 and troughed at -$19.6 million in Q4 2023.
  • The 5-year median for Amortizatization of Intangibles is $1.5 million (2022), against an average of $168000.0.
  • The largest YoY upside for Amortizatization of Intangibles was 1061.53% in 2023 against a maximum downside of 1668.45% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $1.2 million in 2022, then crashed by 1668.45% to -$19.6 million in 2023, then skyrocketed by 49.29% to -$9.9 million in 2024, then skyrocketed by 136.59% to $3.6 million in 2025, then crashed by 85.28% to $535000.0 in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Amortizatization of Intangibles are $535000.0 (Q1 2026), $3.6 million (Q4 2025), and -$1.4 million (Q3 2025).